Trial Profile
Cardiovascular Risk Assessment In Patients With Hypertension And At Least Three Other Risk Factors, Treated With Caduet Compared To Usual Care: The Right Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jan 2021
Price :
$35
*
At a glance
- Drugs Amlodipine/atorvastatin (Primary)
- Indications Cardiovascular disorders; Hypertension
- Focus Therapeutic Use
- Acronyms RIGHT
- Sponsors Pfizer
- 16 Apr 2009 New trial record